A racemic mixture of (R)-dapoxetine and (S)-dapoxetine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

DL-Dapoxetine (hydrochloride)

Item No. 37915

Technical Information
Formal Name
N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine, monohydrochloride
CAS Number
1071929-03-7
Synonyms
  • (±)-Dapoxetine
Molecular Formula
C21H23NO • HCl
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 25 mg/mlDMSO: 16 mg/mlEthanol: 25 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
CN(C)C(C1=CC=CC=C1)CCOC2=CC=CC3=C2C=CC=C3.Cl
InChi Code
InChI=1S/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H
InChi Key
IHWDIQRWYNMKFM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    DL-Dapoxetine is a racemic mixture of the serotonin (5-HT) reuptake inhibitors (R)-dapoxetine and (S)-dapoxetine.1 (S)-Dapoxetine is more potent than (R)-dapoxetine in a serotonin reuptake assay using isolated rat cerebral cortex membranes (IC50s = 10 and 35 nM, respectively).2 (S)-Dapoxetine also inhibits the reuptake of norepinephrine and dopamine in cells expressing the human transporters (IC50s = 202 and 1,720 nM, respectively).3 Formulations containing (S)-dapoxetine have been used in the treatment of premature ejaculation.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kang, S., and Lee, H.-K. Highly efficient, enantioselective syntheses of (S)-(+)- and (R)-(−)-dapoxetine starting with 3-phenyl-1-propanol. The Journal of Organic Chemistry 75(1), 237-240 (2010).

    2. Robertson, D.W., Wong, D.T., and Thompson, D.C. 1-Phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors. US5135947A, (1990).

    3. Gengo, P.J., François, G., McKenna, K.E., et alMonoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation. J. Urol. 173(4), 239 (2005).